We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Mallinckrodt Pharmaceuticals to Acquire Questcor for $5.6B

News   Apr 08, 2014

 
Mallinckrodt Pharmaceuticals to Acquire Questcor for $5.6B
 
 
Advertisement
 

RELATED ARTICLES

Switching Immune Cells From “Protect” to “Attack” Mode To Treat Prostate Cancer

News

Researchers found that immune cells called macrophages, which are typically found in prostate cancer tumors to help promote growth, can be rewired to attack the disease using therapeutics.

READ MORE

Novel Vaccine Removes Aged Immune Cells in Mice

News

In a new study, researchers from Osaka University developed a novel vaccine that removes aged immune cells and then demonstrated an improvement of diabetes-associated metabolic derangements by vaccinating obese mice.

READ MORE

Synthetic DNA-like Molecules a Potential New Treatment for Muscular Dystrophy

News

Researchers have designed a potential new treatment for one of the most common forms of muscular dystrophy, according to a new study published in the Proceedings of the National Academy of Sciences.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE